Laird Norton Trust Company, LLC Cardiol Therapeutics Inc. Transaction History
Laird Norton Trust Company, LLC
- $738 Million
- Q1 2024
A detailed history of Laird Norton Trust Company, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Laird Norton Trust Company, LLC holds 100,000 shares of CRDL stock, worth $196,000. This represents 0.02% of its overall portfolio holdings.
Number of Shares
100,000
Previous 100,000
-0.0%
Holding current value
$196,000
Previous $84,000
115.48%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CRDL
# of Institutions
38Shares Held
6.55MCall Options Held
71.7KPut Options Held
0-
Mmcap International Inc. Spc Grand Cayman, E92.57MShares$5.03 Million0.7% of portfolio
-
Tejara Capital LTD London, X01.64MShares$3.22 Million1.09% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.3MShares$2.55 Million0.41% of portfolio
-
Lion Street Advisors, LLC193KShares$377,6920.13% of portfolio
-
Cambridge Investment Research Advisors, Inc.129KShares$252,3360.0% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $121M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...